Cargando…

Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways

BACKGROUND: The introduction of effective novel biomarkers of invasion and metastasis is integral for the advancement of breast cancer management. The present study focused on the identification and evaluation of calreticulin (CRT) as a potential biomarker for breast cancer invasion. METHODS: Two-di...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamanian, Mohammadreza, Qader Hamadneh, Lama Abdel, Veerakumarasivam, Abhi, Abdul Rahman, Sabariah, Shohaimi, Shamarina, Rosli, Rozita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944499/
https://www.ncbi.nlm.nih.gov/pubmed/27418879
http://dx.doi.org/10.1186/s12935-016-0329-y
_version_ 1782442776129961984
author Zamanian, Mohammadreza
Qader Hamadneh, Lama Abdel
Veerakumarasivam, Abhi
Abdul Rahman, Sabariah
Shohaimi, Shamarina
Rosli, Rozita
author_facet Zamanian, Mohammadreza
Qader Hamadneh, Lama Abdel
Veerakumarasivam, Abhi
Abdul Rahman, Sabariah
Shohaimi, Shamarina
Rosli, Rozita
author_sort Zamanian, Mohammadreza
collection PubMed
description BACKGROUND: The introduction of effective novel biomarkers of invasion and metastasis is integral for the advancement of breast cancer management. The present study focused on the identification and evaluation of calreticulin (CRT) as a potential biomarker for breast cancer invasion. METHODS: Two-dimensional gel protein electrophoresis and MALDI-TOF were utilized in the analysis of fresh-frozen invasive intra-ductal carcinoma specimens. Calreticulin-associated expression was analyzed using immunohistochemistry of FFPE non-malignant/malignant breast specimens. A CRT-knockdown model of MCF7 cell line was developed using siRNA and the CRT genotype/phenotype correlations based on migration and trans-well invasion assays were determined. Finally, microarray-based global gene expression profiling was conducted to elucidate the possible calreticulin pro-invasive regulatory pathways. RESULTS: Two-dimensional gel protein electrophoresis and MALDI-TOF analysis showed upregulation of calreticulin expression in tumor tissues as compared to the normal adjacent tissues. Meta-analysis of the immunohistochemical results confirmed significantly higher expression of calreticulin (p < 0.05) in the stromal compartments of malignant tissues as compared to non-malignant tissues. Migration and transwell invasion assays showed significant loss in the migratory and invasive potential of CRT-knockdown cells (p < 0.05). Global gene expression profiling successfully identified various putative gene networks such as p53 and MAPK pathways that are involved in calreticulin breast cancer signaling. CONCLUSION: Besides confirming calreticulin overexpression in invasive breast cancer tissues, this study reveals a calreticulin-dependent pro-invasive potential and suggests possible contributing pathways. Defining the mechanistic role of invasion and characterizing the possible calreticulin-dependent molecular targets will be the focus of future work. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12935-016-0329-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4944499
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49444992016-07-15 Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways Zamanian, Mohammadreza Qader Hamadneh, Lama Abdel Veerakumarasivam, Abhi Abdul Rahman, Sabariah Shohaimi, Shamarina Rosli, Rozita Cancer Cell Int Primary Research BACKGROUND: The introduction of effective novel biomarkers of invasion and metastasis is integral for the advancement of breast cancer management. The present study focused on the identification and evaluation of calreticulin (CRT) as a potential biomarker for breast cancer invasion. METHODS: Two-dimensional gel protein electrophoresis and MALDI-TOF were utilized in the analysis of fresh-frozen invasive intra-ductal carcinoma specimens. Calreticulin-associated expression was analyzed using immunohistochemistry of FFPE non-malignant/malignant breast specimens. A CRT-knockdown model of MCF7 cell line was developed using siRNA and the CRT genotype/phenotype correlations based on migration and trans-well invasion assays were determined. Finally, microarray-based global gene expression profiling was conducted to elucidate the possible calreticulin pro-invasive regulatory pathways. RESULTS: Two-dimensional gel protein electrophoresis and MALDI-TOF analysis showed upregulation of calreticulin expression in tumor tissues as compared to the normal adjacent tissues. Meta-analysis of the immunohistochemical results confirmed significantly higher expression of calreticulin (p < 0.05) in the stromal compartments of malignant tissues as compared to non-malignant tissues. Migration and transwell invasion assays showed significant loss in the migratory and invasive potential of CRT-knockdown cells (p < 0.05). Global gene expression profiling successfully identified various putative gene networks such as p53 and MAPK pathways that are involved in calreticulin breast cancer signaling. CONCLUSION: Besides confirming calreticulin overexpression in invasive breast cancer tissues, this study reveals a calreticulin-dependent pro-invasive potential and suggests possible contributing pathways. Defining the mechanistic role of invasion and characterizing the possible calreticulin-dependent molecular targets will be the focus of future work. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12935-016-0329-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-13 /pmc/articles/PMC4944499/ /pubmed/27418879 http://dx.doi.org/10.1186/s12935-016-0329-y Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Primary Research
Zamanian, Mohammadreza
Qader Hamadneh, Lama Abdel
Veerakumarasivam, Abhi
Abdul Rahman, Sabariah
Shohaimi, Shamarina
Rosli, Rozita
Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways
title Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways
title_full Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways
title_fullStr Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways
title_full_unstemmed Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways
title_short Calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and MAPK pathways
title_sort calreticulin mediates an invasive breast cancer phenotype through the transcriptional dysregulation of p53 and mapk pathways
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944499/
https://www.ncbi.nlm.nih.gov/pubmed/27418879
http://dx.doi.org/10.1186/s12935-016-0329-y
work_keys_str_mv AT zamanianmohammadreza calreticulinmediatesaninvasivebreastcancerphenotypethroughthetranscriptionaldysregulationofp53andmapkpathways
AT qaderhamadnehlamaabdel calreticulinmediatesaninvasivebreastcancerphenotypethroughthetranscriptionaldysregulationofp53andmapkpathways
AT veerakumarasivamabhi calreticulinmediatesaninvasivebreastcancerphenotypethroughthetranscriptionaldysregulationofp53andmapkpathways
AT abdulrahmansabariah calreticulinmediatesaninvasivebreastcancerphenotypethroughthetranscriptionaldysregulationofp53andmapkpathways
AT shohaimishamarina calreticulinmediatesaninvasivebreastcancerphenotypethroughthetranscriptionaldysregulationofp53andmapkpathways
AT roslirozita calreticulinmediatesaninvasivebreastcancerphenotypethroughthetranscriptionaldysregulationofp53andmapkpathways